EcoDrugPlus

Dopamine Receptor D3

Ensembl ID : ENSCCRG00000019745
Gene Symbol: DRD3
1 Cross references
199 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSCCRG00000024475
Gene Symbol: DRD4A
1 Cross references
172 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSCCRG00000023153
Gene Symbol: DRD4A
1 Cross references
172 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSCCRG00000008515
Gene Symbol: DRD4B
1 Cross references
173 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSCCRG00000006599
Gene Symbol: DRD5
1 Cross references
144 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSCCRG00000035526
Gene Symbol: EGLN1
1 Cross references
209 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSCCRG00000048167
Gene Symbol: EGLN1
1 Cross references
210 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSCCRG00000073675
Gene Symbol: EGLN3
1 Cross references
143 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 3

Ensembl ID : ENSCCRG00000021591
Gene Symbol: EGLN3
1 Cross references
197 Possible Orthologues:

Endothelial Pas Domain Protein 1b

Ensembl ID : ENSCCRG00000027310
Gene Symbol: EPAS1B
1 Cross references
211 Possible Orthologues:

Endothelial Pas Domain Protein 1b

Ensembl ID : ENSCCRG00000024181
Gene Symbol: EPAS1B
1 Cross references
211 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSCCRG00000006396
Gene Symbol: ECE1
1 Cross references
227 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).